查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗感染藥市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測
市場調查報告書
商品編碼
1207152

抗感染藥市場：2023-2028 年全球行業趨勢、份額、規模、增長、機遇和預測

Anti-infectives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022年全球抗感染市場規模將達到1302億美元。 展望未來，IMARC Group 預測到 2028 年將達到 1576 億美元，顯示 2023 年至 2028 年之間的增長率 (CAGR) 為 3.46%。

抗感染藥是對抗感染、抑制感染傳播或徹底殺死感染病原體的藥物。 這些藥物包括抗生素、抗病毒藥、抗真菌藥、抗瘧藥、驅蟲藥、抗原蟲藥等。 它通常通過口服、腸胃外和局部等途徑給藥。 廣泛用於治療肺炎、肺結核等輕微感染。 它還用於嚴重感染風險高的常規程序和手術，例如剖腹產和關節置換術。

抗感染藥市場趨勢

  • 全球抗感染藥市場的主要驅動因素是全球傳染病數量的增加。 抗感染藥物用於治療病毒、細菌、寄生蟲和真菌等感染。 此外，天然產物、群體感應抑製劑、生物膜破壞劑、鎵基藥物、環糊精抑製劑和光基抗菌劑等不同策略的新藥開發正在推動市場增長。我正在獲得動力. 與此同時，藥物發現程序的最新創新，如乾細胞和片上器官 (OOC) 技術，正在加強藥物發現測試過程，並為市場創造光明的前景。 此外，由於 COVID-19 疾病的出現和曲霉菌病、侵襲性念珠菌病和粘菌病等誘發的感染，產品採用率的提高正在加強市場增長。 此外，越來越多的新型抗感染藥獲得監管部門批准也是推動增長的一個因素。 此外，政府實施利好政策、加大對創新藥物開發的投入、公眾對傳染病的認識提高、醫療基礎設施的快速改善等都有望在未來幾年推動市場增長。我是這裡。

主要市場細分

  • IMARC Group 分析了全球抗感染藥市場報告每個子細分市場的主要趨勢，並提供了 2023 年至 2028 年全球、區域和國家層面的預測。 該報告根據類型、給藥途徑和分銷渠道對市場進行分類。

按類型細分

  • 抗菌劑
  • 抗真菌劑
  • 抗病毒劑

按給藥途徑分類

  • 外用
  • 口語
  • 靜脈給藥 (IV)
  • 其他

按銷售渠道細分

  • 醫院藥房
  • 零售藥房
  • 專業藥房
  • 在線商店
  • 其他

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

本報告中回答的關鍵問題

  • 全球抗感染藥市場到目前為止表現如何，未來幾年會是什麼樣子？
  • COVID-19 對全球抗感染藥市場有何影響？
  • 主要的區域市場是什麼？
  • 市場是如何按類型細分的？
  • 基於給藥途徑的市場細分是什麼？
  • 按分銷渠道劃分的市場細分情況如何？
  • 行業價值鏈中有哪些不同階段？
  • 該行業的主要驅動因素和挑戰是什麼？
  • 全球抗感染藥市場的結構和主要參與者是什麼？
  • 該行業的競爭程度如何？

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第五章全球抗感染藥物市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按類型劃分的市場細分

  • 抗菌劑
    • 市場趨勢
    • 市場預測
  • 抗真菌劑
    • 市場趨勢
    • 市場預測
  • 抗病毒劑
    • 市場趨勢
    • 市場預測

第 7 章按管理劃分的市場細分

  • 外科學
    • 市場趨勢
    • 市場預測
  • 口服劑
    • 市場趨勢
    • 市場預測
  • 靜脈給藥 (IV)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章分銷渠道市場細分

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥房
    • 市場趨勢
    • 市場預測
  • 專業藥房
    • 市場趨勢
    • 市場預測
  • 在線商店
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 10 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第11章價值鏈分析

第12章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Abbott Laboratories
    • Cipla Health Ltd.（Cipla Limited）
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson
    • Lupin Limited
    • Sandoz AG（Novartis AG）
    • Sun Pharmaceutical Industries Limited
Product Code: SR1323A624_Report

The global anti-infectives market size reached US$ 130.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 157.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.46% during 2023-2028.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

  • The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-infectives market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration and distribution channel.

Breakup by Type:

  • Antibacterial
  • Antifungal
  • Antiviral

Breakup by Route of Administration:

  • Topical
  • Oral
  • Intravenous (IV)
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Speciality Pharmacies
  • Online Stores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report:

  • How has the global anti-infectives market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-infectives market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-infectives market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-infectives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Antibacterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antifungal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antiviral
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intravenous (IV)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cipla Health Ltd. (Cipla Limited)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 GlaxoSmithKline plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Glenmark Pharmaceuticals Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Lupin Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sandoz AG (Novartis AG)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-infectives Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Anti-infectives Industry: SWOT Analysis
  • Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
  • Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Anti-infectives Market: Competitive Structure
  • Table 7: Global: Anti-infectives Market: Key Players